Matthew R Sydes
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
Vogl U, Mottet N, Padhani A, Roach M, Rubin M, Sartor O, Small E, Smith M, Soule H, Sydes M, Tombal B, Omlin A, Gillessen S, James N, Halabi S, Beer T, Davis I, Shore N, Sweeney C, Ost P, Attard G, Bossi A, de Bono J, Drake C, Efstathiou E, Fanti S, Fizazi K, APCCC 2019 expert panel. Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings. Eur J Cancer 2021; 160:24-60.
26.11.2021Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
26.11.2021Eur J Cancer 2021; 160:24-60
Vogl Ursula M, Mottet Nicolas, Padhani Anwar R, Roach Mack, Rubin Mark, Sartor Oliver, Small Eric, Smith Matthew R, Soule Howard, Sydes Matthew R, Tombal Bertrand, Omlin Aurelius, Gillessen Silke, James Nicolas, Halabi Susan, Beer Tomasz M, Davis Ian D, Shore Neal D, Sweeney Christopher J, Ost Piet, Attard Gerhardt, Bossi Alberto, de Bono Johann, Drake Charles G, Efstathiou Eleni, Fanti Stefano, Fizazi Karim, APCCC 2019 expert panel
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
Omlin A, Ryan C, Rubin M, Roach M, Reiter R, Pritchard C, Poon D, Parker C, Padhani A, O'Sullivan J, Ost P, Oh W, Murthy V, Murphy D, Mrabti H, Mottet N, Morris M, Saad F, Sade J, Zapatero A, van Oort I, Türkeri L, Tombal B, Taplin M, Sydes M, Sweeney C, Suzuki H, Steuber T, Sternberg C, Soule H, Smith M, Small E, Shore N, Scher H, Sartor O, Morgans A, Millman R, Evans C, Efstathiou E, Eeles R, Duran I, Drake C, de Bono J, Davis I, Clarke N, Chi K, Bristow R, Briganti A, Bossi A, Bjartell A, Beltran H, Beer T, Attard G, Fanti S, Feng F, Maluf F, Logothetis C, Leibowitz R, Khauli R, Kantoff P, Kanesvaran R, James N, Hussain M, Hofman M, Higano C, Heinrich D, Heidenreich A, Halabi S, Gleave M, Frydenberg M, Fizazi K, Gillessen S. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol 2020; 77:508-547.
27.01.2020Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
27.01.2020Eur Urol 2020; 77:508-547
Omlin Aurelius, Ryan Charles J, Rubin Mark, Roach Mack, Reiter Robert E, Pritchard Colin C, Poon Darren M C, Parker Chris, Padhani Anwar R, O'Sullivan Joe M, Ost Piet, Oh William K, Murthy Vedang, Murphy Declan G, Mrabti Hind, Mottet Nicolas, Morris Michael J, Saad Fred, Sade Juan Pablo, Zapatero Almudena, van Oort Inge, Türkeri Levent, Tombal Bertrand, Taplin Mary-Ellen, Sydes Matthew R, Sweeney Christopher, Suzuki Hiroyoshi, Steuber Thomas, Sternberg Cora N, Soule Howard, Smith Matthew, Small Eric, Shore Neal, Scher Howard I, Sartor Oliver, Morgans Alicia K, Millman Robin, Evans Christopher P, Efstathiou Eleni, Eeles Ros, Duran Ignacio, Drake Charles G, de Bono Johann, Davis Ian D, Clarke Noel, Chi Kim N, Bristow Rob G, Briganti Alberto, Bossi Alberto, Bjartell Anders, Beltran Himisha, Beer Tomasz M, Attard Gerhardt, Fanti Stefano, Feng Felix Y, Maluf Fernando, Logothetis Chris, Leibowitz Raya, Khauli Raja B, Kantoff Philip, Kanesvaran Ravindran, James Nicolas, Hussain Maha, Hofman Michael S, Higano Celestia Tia S, Heinrich Daniel, Heidenreich Axel, Halabi Susan, Gleave Martin, Frydenberg Mark, Fizazi Karim, Gillessen Silke
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer
Hoyle A, Aebersold D, Jones R, Matheson D, Millman R, Mason M, Ritchie A, Russell M, Douis H, Parmar M, Sydes M, Clarke N, Gillessen Sommer S, Ingleby F, Ali A, James N, Cook A, Parker C, de Bono J, Attard G, Chowdhury S, Cross W, Dearnaley D, Brawley C, Gilson C, STAMPEDE Investigators. Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer. Eur Urol 2019; 76:719-728.
23.08.2019Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer
23.08.2019Eur Urol 2019; 76:719-728
Hoyle Alex P, Aebersold Daniel M, Jones Rob J, Matheson David, Millman Robin, Mason Malcolm D, Ritchie Alastair W S, Russell Martin, Douis Hassan, Parmar Mahesh K B, Sydes Matthew R, Clarke Noel W, Gillessen Sommer Silke, Ingleby Fiona, Ali Adnan, James Nicholas D, Cook Adrian, Parker Christopher C, de Bono Johann S, Attard Gerhardt, Chowdhury Simon, Cross William R, Dearnaley David P, Brawley Christopher D, Gilson Clare, STAMPEDE Investigators
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols
Schiavone F, Langley R, Kaplan R, Parker C, Attard G, Clarke N, Gillessen Sommer S, James N, Maughan T, Sydes M, Parmar M, Hudson F, Bathia R, Letchemanan K, Masters L, Amos C, Bara A, Brown L, Gilson C, Pugh C, Atako N, past and present members of the STAMPEDE and FOCUS4 Trial Management Group. This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols. Trials 2019; 20:264.
29.05.2019This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols
29.05.2019Trials 2019; 20:264
Schiavone Francesca, Langley Ruth, Kaplan Richard S, Parker Chris, Attard Gert, Clarke Noel W, Gillessen Sommer Silke, James Nicholas D, Maughan Tim, Sydes Matthew R, Parmar Mahesh, Hudson Fleur, Bathia Riya, Letchemanan Krishna, Masters Lindsey, Amos Claire, Bara Anna, Brown Louise, Gilson Clare, Pugh Cheryl, Atako Nafisah, past and present members of the STAMPEDE and FOCUS4 Trial Management Group
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Systemic Therapy for Advanced or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigators, Jonnada S, Gannon M, Gale J, Eswar C, Douis H, Din O, Birtle A, Bahl A, Khaksar S, Lester J, O'Sullivan J, Sydes M, Parmar M, Tran A, Srihari N, Sheehan D, Pudney D, Pedley I, Parikh O, Alonzi R, Amos C, Thalmann G, Chowdhury S, Attard G, Ritchie A, Ali A, Hoyle A, Clarke N, Brawley C, James N, Cross W, Dearnaley D, Gillessen Sommer S, Russell J, Millman R, Matheson D, Mason M, Malik Z, Langley R, Jones R, Gilson C, Parker C. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Lancet 2018; 392:2353-2366.
21.10.2018Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
21.10.2018Lancet 2018; 392:2353-2366
Systemic Therapy for Advanced or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigators, Jonnada Sai, Gannon Melissa R, Gale Joanna, Eswar Chinnamani, Douis Hassan, Din Omar, Birtle Alison, Bahl Amit, Khaksar Sara, Lester Jason F, O'Sullivan Joe M, Sydes Matthew R, Parmar Mahesh K B, Tran Anna T H, Srihari Narayanan Nair, Sheehan Denise J, Pudney Delia M, Pedley Ian D, Parikh Omi A, Alonzi Roberto, Amos Claire L, Thalmann George N, Chowdhury Simon, Attard Gerhardt, Ritchie Alastair W S, Ali Adnan, Hoyle Alex P, Clarke Noel W, Brawley Christopher D, James Nicholas D, Cross William, Dearnaley David P, Gillessen Sommer Silke, Russell J Martin, Millman Robin, Matheson David, Mason Malcolm D, Malik Zafar I, Langley Ruth E, Jones Robert J, Gilson Clare, Parker Christopher C
Influence of an International Consensus Conference on Practice Patterns in Advanced Prostate Cancer
Gong J, Omlin A, Pal S, Hsu J, Tombal B, Sydes M, Gillessen Sommer S. Influence of an International Consensus Conference on Practice Patterns in Advanced Prostate Cancer. Eur Urol 2018
03.05.2018Influence of an International Consensus Conference on Practice Patterns in Advanced Prostate Cancer
03.05.2018Eur Urol 2018
Gong Jun, Omlin Aurelius, Pal Sumanta K, Hsu J, Tombal Bertrand, Sydes Matthew R, Gillessen Sommer Silke
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Omlin A, Ryan C, Rubin M, Roach M, Pritchard C, Parker C, Padhani A, Ost P, Oh W, Murthy V, Mottet N, Morris M, Morgans A, Maluf F, Saad F, Sartor O, Wiegel T, Valdagni R, Tombal B, Tannock I, Sydes M, Sweeney C, Suzuki H, Sternberg C, Soule H, Smith M, Shore N, Sella A, Scher H, Logothetis C, Kramer G, Khauli R, Dos Reis R, de Bono J, Davis I, Daugaard G, Clarke N, Chung B, Castellano D, Carver B, Bristow R, Bossi A, Beltran H, Beer T, Attard G, Drake C, Eeles R, Kellokumpu-Lehtinen P, Kantoff P, James N, Higano C, Heidenreich A, Halabi S, Gleave M, Frydenberg M, Fizazi K, Feng F, Fanti S, Evans C, Efstathiou E, Gillessen Sommer S. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2017
24.06.2017Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
24.06.2017Eur Urol 2017
Omlin Aurelius, Ryan Charles, Rubin Mark A, Roach Mack, Pritchard Colin C, Parker Chris, Padhani Anwar R, Ost Piet, Oh William, Murthy Vedang, Mottet Nicolas, Morris Michael J, Morgans Alicia K, Maluf Fernando, Saad Fred, Sartor Oliver, Wiegel Thomas, Valdagni Riccardo, Tombal Bertrand, Tannock Ian, Sydes Matthew R, Sweeney Christopher, Suzuki Hiroyoshi, Sternberg Cora N, Soule Howard, Smith Matthew, Shore Neal, Sella Avishay, Scher Howard, Logothetis Chris, Kramer Gero, Khauli Raja B, Dos Reis Rodolfo Borges, de Bono Johann, Davis Ian D, Daugaard Gedske, Clarke Noel, Chung Byung Ha, Castellano Daniel, Carver Brett, Bristow Rob, Bossi Alberto, Beltran Himisha, Beer Tomasz M, Attard Gerhardt, Drake Charles G, Eeles Ros, Kellokumpu-Lehtinen Pirkko-Liisa, Kantoff Philip, James Nicolas, Higano Celestia S, Heidenreich Axel, Halabi Susan, Gleave Martin, Frydenberg Mark, Fizazi Karim, Feng Felix, Fanti Stefano, Evans Christopher P, Efstathiou Eleni, Gillessen Sommer Silke
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
STAMPEDE Investigators, McPhail N, McKinna F, Malik Z, Lester J, Hoskin P, Hingorani M, Gray E, Gale J, Ferguson C, Chakraborti P, Money-Kyrle J, O'Sullivan J, Sydes M, Parmar M, Zarkar A, Wylie J, Wagstaff J, Thomas C, Srihari N, Robinson A, Protheroe A, Parikh O, Brock S, Bowen J, Matheson D, Jones R, Gilson C, Amos C, Ritchie A, Dearnaley D, Mason M, Clarke N, Spears M, de Bono J, Millman R, Attard G, Birtle A, Aung S, Adab F, Brawley C, Berthold D, Russell J, Parker C, Gillessen Sommer S, Cross W, Chowdhury S, James N. Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy. N Engl J Med 2017; 377:338-351.
03.06.2017Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
03.06.2017N Engl J Med 2017; 377:338-351
STAMPEDE Investigators, McPhail Neil, McKinna Fiona, Malik Zafar I, Lester Jason F, Hoskin Peter J, Hingorani Mohan, Gray Emma, Gale Joanna, Ferguson Catherine, Chakraborti Prabir, Money-Kyrle Julian, O'Sullivan Joe, Sydes Matthew R, Parmar Mahesh K B, Zarkar Anjali, Wylie James, Wagstaff John, Thomas Carys, Srihari Narayanan N, Robinson Angus, Protheroe Andrew, Parikh Omi, Brock Susannah, Bowen Jo, Matheson David, Jones Rob J, Gilson Clare, Amos Claire L, Ritchie Alastair W S, Dearnaley David P, Mason Malcolm D, Clarke Noel W, Spears Melissa R, de Bono Johann S, Millman Robin, Attard Gerhardt, Birtle Alison J, Aung San, Adab Fawzi, Brawley Chris, Berthold Dominik R, Russell J Martin, Parker Christopher C, Gillessen Sommer Silke, Cross William R, Chowdhury Simon, James Nicholas D
Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform
Gillessen Sommer S, Gilson C, James N, Adler A, Sydes M, Clarke N. Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform. Eur Urol 2016; 70:906-908.
19.07.2016Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform
19.07.2016Eur Urol 2016; 70:906-908
Gillessen Sommer Silke, Gilson Clare, James Nick, Adler Amanda, Sydes Matthew R, Clarke Noel
Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial
James N, Elliott T, Matheson D, O'Sullivan J, Pudney D, Srihari N, Wallace J, Barber J, Syndikus I, Parmar M, Sydes M, Engeler D, Birtle A, Spears M, Clarke N, Dearnaley D, Mason M, Parker C, Ritchie A, Russell J, Schiavone F, Attard G, de Bono J. Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial. JAMA Oncol 2016; 2:348-57.
01.03.2016Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial
01.03.2016JAMA Oncol 2016; 2:348-57
James Nicholas D, Elliott Tony, Matheson David, O'Sullivan Joe, Pudney Delia, Srihari Narayanan, Wallace Jan, Barber Jim, Syndikus Isabel, Parmar Mahesh K B, Sydes Matthew R, Engeler Daniel, Birtle Alison, Spears Melissa R, Clarke Noel W, Dearnaley David P, Mason Malcolm D, Parker Christopher C, Ritchie Alastair W S, Russell J Martin, Schiavone Francesca, Attard Gerhardt, de Bono Johann S